---
canonical_name: Insoles
alternate_names: Shoe Insoles, Foot Orthoses, Foot Orthotics, Orthotic Insoles, Orthotics, Shoe Inserts, Arch Supports
canonical_topic: Insoles for Health & Longevity
short_topic_lc: insoles
creation_date: 2026-0929-2156
creator_ai_fullname: Sonnet 5.5
ep_keywords: Orthopedic Devices, Podiatry, Footwear
---

# Insoles for Health & Longevity
<section id="top" markdown="1"></section>  
Evidence Review created on 09/29/2026 using [AI4L](https://github.com/forever-healthy/AI4L) / Sonnet 5.5  

**Also known as:** Shoe Insoles, Foot Orthoses, Foot Orthotics, Orthotic Insoles, Orthotics, Shoe Inserts, Arch Supports

  
## Motivation

<!-- Motivation was written last, after all other sections were completed, so that it reflects the full scope of the review. -->

Insoles (also called shoe inserts, foot orthoses, or orthotics) are removable devices placed inside footwear to cushion the foot, support its arch, spread pressure across the sole, or add sensation underfoot. They range from inexpensive over-the-counter pads to custom-made devices built from a foot scan, and newer designs include textured, vibrating, and sensor-equipped versions. The feet are the body's only contact with the ground, which is why what sits beneath them draws interest.

Insoles have long been prescribed for foot pain. Interest has since widened to diabetic foot sores and steadiness in older adults. A recurring debate asks whether supporting the foot helps it or leaves its own muscles less used, a question that divides supportive and minimal footwear approaches.

This review examines what the evidence shows for insoles in health- and longevity-oriented adults: which conditions and outcomes have been studied, how strong the supporting data are, what harms are known, and how the sources of that evidence, including manufacturers and professional groups, shape it.

**[Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol) - [Conclusion](#conclusion)**

  
## Recommended Reading

Expert commentary and non-systematic articles that give a high-level overview of insoles and the foot-support debate.

<!-- Author search statement: Real-time searches were run on 2026-09-29. Web searches for "<expert> insoles/orthotics/footwear" were run for Rhonda Patrick, Peter Attia, Andrew Huberman, Chris Kresser, Life Extension Magazine, and Lifespan.io, and on-site searches were run at foundmyfitness.com (no insole content; 8 unrelated results), hubermanlab.com (only a toe-spreading and foot-strength timestamp, nothing on insoles), chriskresser.com (no results for "insoles"; "orthotics" returned two episodes, one mentioning orthotics only in passing within a barefoot-training discussion and therefore not qualifying), lifespan.io (no results for "insoles" or "orthotics"), and lifeextension.com (search results not rendered by any retrieval tier). Peter Attia's site yielded two foot-related episodes; the one discussing orthotics by name in most depth was selected. Excluded per rules: Grokipedia, Examine, ConsumerLab, systematic reviews, encyclopedias, forums, mainstream media, and database or catalogue entries. -->

* [#128 – Irene Davis, Ph.D.: Evolution of the foot, running injuries, and minimalist shoes](https://peterattiamd.com/irenedavis/) - Peter Attia

  A running-injury researcher describes moving from prescribing orthotics to minimalist footwear (thin, flexible, low-cushion shoes) and outlines a protocol for transitioning patients out of orthotics.

Note: Fewer than five qualifying sources were found, and the list is not padded with marginally relevant content. No relevant content on insoles was found from Rhonda Patrick (FoundMyFitness), Andrew Huberman (whose foot content addresses toe training, not insoles), Chris Kresser (whose only orthotics mention is in passing within a barefoot-training episode), Life Extension Magazine, or Lifespan.io.

  
## Grokipedia

<!-- Author search statement: grokipedia.com was searched directly for "insoles". d-browser loaded https://grokipedia.com/search?q=insoles and returned 438 results, including an article titled "Shoe insert" (also known as foot orthotics or insoles). d-browser then loaded https://grokipedia.com/page/Shoe_insert, the genuine article. Other tested titles (Insole, Foot orthosis, Foot orthotics, Orthotic insole) returned "Article not found"; "Orthotics" is a broad article on all orthoses, not the insole-specific page. -->

[Shoe insert](https://grokipedia.com/page/Shoe_insert)

AI-generated encyclopedic overview of insert types (soft, semi-rigid, rigid), materials, and therapeutic uses, including diabetic and balance applications.

  
## Examine

<!-- Author search statement: examine.com was searched directly for "insoles". d-browser returned a Vercel Security Checkpoint (bot wall); d-fetch returned HTTP 429; d-proxy-1 loaded https://examine.com/search/?q=insoles and returned "Sorry, there are no search results for insoles"; d-proxy-2 returned the same result. -->

No Examine article on insoles or foot orthoses exists; examine.com covers supplements and nutrition, and its search for "insoles" returned no results.

  
## ConsumerLab

<!-- Author search statement: consumerlab.com was searched directly for "insoles". d-browser loaded https://www.consumerlab.com/search/?q=insoles and returned "Sorry, we didn't find any results for insoles"; d-fetch returned the same result. A search for "orthotics" returned only an answer about supplements for plantar fasciitis, not an article on insoles. -->

No ConsumerLab article on insoles or foot orthoses exists; consumerlab.com tests supplements and food products, and its search for "insoles" returned no results.

  
## Systematic Reviews

Systematic reviews and meta-analyses (structured searches of all trials on a question, with results pooled statistically) on insoles and foot orthoses.

<!-- Author search statement: A real-time PubMed search was run on 2026-09-29 for (insoles OR foot orthoses OR orthotics) AND (systematic review OR meta-analysis), plus topic-specific searches (falls and balance in older adults, diabetic foot ulcers, knee osteoarthritis, plantar heel pain, injury prevention, low back pain). Selection prioritized relevance to health and longevity outcomes, recency, study size, and coverage of both the claimed effects and the principal cost or risk. -->

* [Prevention of foot ulcers in persons with diabetes at risk of ulceration: A systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/37243880/) - van Netten et al., 2024

  Graded review of foot ulcer (open sore) prevention in diabetes; pressure-optimised footwear or insoles likely reduce plantar (sole-side) ulcer recurrence, with moderate certainty.

* [Effectiveness of foot orthoses and shock-absorbing insoles for the prevention of injury: a systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/27919918/) - Bonanno et al., 2017

  Foot orthoses reduced stress fractures (overuse bone cracks) and overall injuries; shock-absorbing insoles prevented none. Eighteen trials, of variable quality.

* [Foot orthoses for plantar heel pain: a systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/28935689/) - Whittaker et al., 2018

  Nineteen trials of orthoses for pain under the heel: moderate-quality medium-term pain reduction, none short- or long-term; custom no better than prefabricated.

* [Effects of somatosensory stimulation foot orthoses on balance and stability in older adults: A systematic review, meta-analysis, and meta-regression](https://pubmed.ncbi.nlm.nih.gov/40998603/) - Jor et al., 2026

  Eighteen studies: less postural sway (standing body movement) and faster timed walking, no clear gait or mobility gains. One author works for an orthosis company.

* [The effect of foot orthoses and insoles on running economy and performance in distance runners: A systematic review and meta-analysis](https://pubmed.ncbi.nlm.nih.gov/31423908/) - Crago et al., 2019

  Nine studies: orthoses and shock-absorbing insoles associated with small negative effects on running economy (oxygen cost of running).

No systematic review was found that quantifies blisters or other minor adverse events of insoles, or intrinsic foot muscle changes (changes in the small muscles inside the foot) with insole use; these principal risks are unrepresented. Two of the reviews above (Bonanno et al., Whittaker et al.) come from a university podiatry department, a profession that supplies orthoses.

  
## Mechanism of Action

Insoles act mechanically and through sensation, and several proposed mechanisms compete.

* **Kinematic (motion) change:** Insoles with a built-in wedge (posted) or a contoured shape alter foot position, reducing peak rearfoot eversion (inward roll of the heel) by about 2 degrees in uninjured adults, in a meta-analysis of gait studies ([Mills et al., 2010](https://pubmed.ncbi.nlm.nih.gov/19996330/)).
* **Pressure redistribution:** Arch contours and metatarsal (forefoot) pads spread load away from high-pressure zones. In neuropathy (nerve damage that reduces sensation), this lowers peak plantar pressure (the highest pressure under the sole) ([Collings et al., 2021](https://pubmed.ncbi.nlm.nih.gov/33532602/)).
* **Shock attenuation:** Moulded orthoses reduced impact force and its rate of build-up (loading rate) in gait laboratories ([Mills et al., 2010](https://pubmed.ncbi.nlm.nih.gov/19996330/)), yet shock-absorbing insoles did not prevent injuries in trials ([Bonanno et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27919918/)).
* **Sensory modulation:** Textured or vibrating surfaces are thought to stimulate mechanoreceptors (touch-sensing nerve endings) in the sole; random low-level vibration was proposed to enhance balance signals ([Priplata et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14550702/)).
* **Competing view, disuse:** Critics argue that permanent support reduces demand on the intrinsic foot muscles (the small muscles inside the foot). Custom orthoses were followed by 10–17% smaller cross-sectional area (muscle thickness on ultrasound) in one small study ([Protopapas & Perry, 2020](https://pubmed.ncbi.nlm.nih.gov/32521283/)), whereas minimalist-shoe walking increased muscle size and strength ([Ridge et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30113521/)).
* **Competing view, alignment:** Matching shoes to arch height did not change injury rates in about 7,200 military recruits, suggesting alignment correction is not the whole mechanism ([Knapik et al., 2014](https://pubmed.ncbi.nlm.nih.gov/25155917/)).

  
## Historical Context & Evolution

Foot supports originated as arch braces for painful flatfoot in the late nineteenth century, and mass-produced arch supports were marketed from the early twentieth century. Custom "functional" orthoses followed, built on the premise that abnormal foot alignment, such as overpronation (excessive inward roll of the foot), causes lower-limb problems. Use then expanded from foot pain to running injuries, arthritis, and back pain.

Two developments extended interest toward longevity. In diabetes care, pressure-relieving footwear and inserts became central to ulcer prevention, as a systematic review of trials concluded that pressure-relieving footwear, when worn, prevents plantar ulcer recurrence ([Bus et al., 2016](https://pubmed.ncbi.nlm.nih.gov/26342178/)). In older-adult care, standing on gel insoles with random low-level vibration reduced sway in 27 young and older participants ([Priplata et al., 2003](https://pubmed.ncbi.nlm.nih.gov/14550702/)), opening interest in sensory insoles for balance and falls.

Scientific opinion has shifted on both sides. Alignment-based prescribing was questioned when trials in roughly 7,200 military recruits found no change in injury rates when shoes were matched to arch height ([Knapik et al., 2014](https://pubmed.ncbi.nlm.nih.gov/25155917/)). A review of gait studies found orthoses modestly alter foot motion, with the sensory (neuromotor) mechanism least conclusive ([Mills et al., 2010](https://pubmed.ncbi.nlm.nih.gov/19996330/)). Some clinicians, including physical therapist Irene Davis, moved from prescribing orthotics toward minimalist footwear ([Attia and Davis podcast](https://peterattiamd.com/irenedavis/)), while controlled trials continue to report benefits for specific conditions. The current standing remains contested.

  
## Expected Benefits

<!-- Author search statement: A dedicated search for the complete benefit profile was run on 2026-09-29 using PubMed (systematic reviews, Cochrane reviews, and randomized trials by condition: diabetic foot ulcers, injury prevention, plantar heel pain, falls and balance, knee osteoarthritis, patellofemoral pain, low back pain, rheumatoid arthritis, hallux valgus, flatfoot, running), ClinicalTrials.gov, and expert commentary. Most trials come from podiatry research groups, a profession that prescribes orthoses, and some device trials were manufacturer-funded. -->

### High 🟩 🟩 🟩

#### Fewer stress fractures and overuse injuries in high-load training

In trials mostly of military recruits, contoured foot orthoses were associated with fewer stress fractures (overuse bone cracks) and fewer injuries overall, whereas shock-absorbing insoles were not ([Bonanno et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27919918/)). Trial quality varied; a later trial in naval recruits found a non-significant 34% lower injury incidence ([Bonanno et al., 2018](https://pubmed.ncbi.nlm.nih.gov/29056595/)). Applicability to non-military adults in high-volume training is inferred.

**Magnitude:** Relative risk (RR, risk in the treated group divided by risk in the control group) 0.59 (95% confidence interval, CI, the range likely to contain the true value: 0.45–0.76) for stress fractures and RR 0.72 (CI 0.55–0.94) for overall injuries with foot orthoses; RR 0.79 (CI 0.55–1.14) for soft-tissue injuries, not significant ([Bonanno et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27919918/)).

#### Medium-term plantar heel pain relief

In 19 trials of adults with plantar heel pain (pain under the heel), foot orthoses reduced pain more than sham (inactive look-alike) orthoses at 7–12 weeks, on moderate-quality evidence, but not at 0–6 or 13–52 weeks ([Whittaker et al., 2018](https://pubmed.ncbi.nlm.nih.gov/28935689/)). An earlier trial found small function gains at 3 months and none at 12 months ([Landorf et al., 2006](https://pubmed.ncbi.nlm.nih.gov/16801514/)). Customized and prefabricated orthoses performed similarly, and clinical importance is uncertain.

**Magnitude:** Standardized mean difference (SMD, effect size in standard-deviation units) −0.27 (CI −0.48 to −0.06) for pain at 7–12 weeks versus sham orthoses ([Whittaker et al., 2018](https://pubmed.ncbi.nlm.nih.gov/28935689/)).

### Medium 🟩 🟩

#### Foot pain relief in high-arched feet, bunions, and rheumatoid arthritis ⚠️ Conflicted

In a Cochrane review from 2008, custom-made foot orthoses relieved pain in painful pes cavus (high-arched feet; one trial), painful hallux valgus (bunion, a sideways big-toe deformity; one trial), and rearfoot pain in rheumatoid arthritis (autoimmune joint inflammation, three trials in foot pain). Trials were few and small ([Hawke et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18646168/)). A 2022 review pooling bunion trials found no significant pain effect from foot orthoses ([Hurn et al., 2022](https://pubmed.ncbi.nlm.nih.gov/33768721/)). Net reading: benefit likely for high-arched feet and rheumatoid arthritis, uncertain for bunions.

**Magnitude:** Number needed to treat for benefit (NNTB, people treated for one to benefit) of 5 for pes cavus, 6 for hallux valgus, and 4 for rearfoot pain in rheumatoid arthritis ([Hawke et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18646168/)).

#### Fewer plantar ulcer recurrences in high-risk diabetic feet ⚠️ Conflicted

In adults with diabetes, reduced foot sensation, and a healed ulcer, pressure-relieving custom footwear and insoles were associated with fewer repeat ulcers in pooled randomized controlled trials (RCTs, studies assigning participants by chance) ([Crawford et al., 2020](https://pubmed.ncbi.nlm.nih.gov/31773194/)), yet a later review pooled only 2 RCTs of footwear or insoles, with a non-significant estimate ([van Netten et al., 2024](https://pubmed.ncbi.nlm.nih.gov/37243880/)). A proof-of-concept RCT of sensor insoles, co-funded by the maker, found fewer ulcers at monitored sites ([Abbott et al., 2019](https://pubmed.ncbi.nlm.nih.gov/33323253/)). Net reading: benefit likely for diabetic adults, with imprecise insole-specific data.

**Magnitude:** RR of ulcer recurrence 0.53 (CI 0.33–0.85) for custom-made footwear and pressure-relieving insoles ([Crawford et al., 2020](https://pubmed.ncbi.nlm.nih.gov/31773194/)); RR 0.62 (CI 0.26–1.47) for pressure-optimised footwear or insoles in 2 RCTs ([van Netten et al., 2024](https://pubmed.ncbi.nlm.nih.gov/37243880/)); incidence rate ratio (IRR, ratio of event rates) 0.29 (CI 0.09–0.93) for sensor insoles, 4 versus 10 ulcers ([Abbott et al., 2019](https://pubmed.ncbi.nlm.nih.gov/33323253/)).

### Low 🟩

#### Acute balance and gait gains with textured or vibrating insoles ⚠️ Conflicted

A meta-analysis of immediate tests found less postural sway and faster Timed Up and Go (timed rise-walk-return test) with textured orthoses in older adults ([Jor et al., 2026](https://pubmed.ncbi.nlm.nih.gov/40998603/)); older fallers walked slower in textured insoles ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)). Net reading: acute gains in some groups, not older fallers.

**Magnitude:** Timed Up and Go time −1.15 seconds (CI −1.82 to −0.47) ([Jor et al., 2026](https://pubmed.ncbi.nlm.nih.gov/40998603/)); SMD 0.75 (CI 0.18–1.33) for sway with eyes closed on textured materials, with effects varying between studies ([Kenny et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31022658/)); walking speed rose in all seven vibrating-insole settings, and stair-ascent speed rose from 0.447 to 0.517 meters per second in the best-performing setting ([Orlando et al., 2024](https://pubmed.ncbi.nlm.nih.gov/38536962/)).

#### Fewer falls with multifaceted podiatry care including orthoses ⚠️ Conflicted

Two RCTs tested podiatry packages (foot orthoses, footwear advice, foot exercises) in older adults. One found a lower fall rate ([Spink et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21680622/)); the larger one did not reach significance ([Cockayne et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28621259/)). Effects cannot be attributed to orthoses alone. Net reading: possible benefit, inconsistent across trials.

**Magnitude:** Incidence rate ratio 0.64 (CI 0.45–0.91) in 305 adults with disabling foot pain ([Spink et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21680622/)) versus 0.88 (CI 0.73–1.05) in 1,010 adults ([Cockayne et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28621259/)).

#### Knee pain relief with lateral wedge insoles in medial knee osteoarthritis ⚠️ Conflicted

Lateral wedges aim to relieve the inner knee in medial knee osteoarthritis (inner-joint wear). A trial found no pain benefit ([Bennell et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21593096/)); a trial in screened adults found a small one ([Felson et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30615299/)). Net reading: no overall benefit, small benefit possible in responders.

**Magnitude:** Pain difference −0.3 points (CI −1.0 to 0.3, 0–10 scale) versus flat insoles at 12 months in 200 adults ([Bennell et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21593096/)); a pooled analysis of 13 RCTs found no significant pain or function difference ([Yu et al., 2021](https://pubmed.ncbi.nlm.nih.gov/33904586/)); 0.7 points better (CI 0.1–1.2) in prescreened responders ([Felson et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30615299/)).

#### Short-term kneecap pain improvement with foot orthoses ⚠️ Conflicted

In patellofemoral pain (pain around the kneecap), foot orthoses beat sham on patient-rated overall change at 3 months ([Neal et al., 2022](https://pubmed.ncbi.nlm.nih.gov/36070427/)); a pooled analysis with mixed comparators found better knee function but no pain reduction ([Chen et al., 2022](https://pubmed.ncbi.nlm.nih.gov/35721679/)). Net reading: short-term functional benefit likely, pain effect inconsistent.

**Magnitude:** Odds ratio (OR, ratio of odds) 4.31 (CI 1.48–12.56) for global rating of change ([Neal et al., 2022](https://pubmed.ncbi.nlm.nih.gov/36070427/)); knee function SMD −0.45 (CI −0.74 to −0.16) and pain SMD −0.01 (CI −0.32 to 0.30) ([Chen et al., 2022](https://pubmed.ncbi.nlm.nih.gov/35721679/)).

#### Low back pain relief ⚠️ Conflicted

A 2014 review found no effect on treatment or prevention ([Chuter et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24775807/)), whereas later reviews found less pain with custom orthotics (moderate certainty; [Kong et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32954802/)) and foot orthoses (low certainty; [Lin et al., 2026](https://pubmed.ncbi.nlm.nih.gov/40844962/)); preformed devices showed no effect. Net reading: possible benefit, low certainty.

**Magnitude:** Treatment SMD −0.74 (CI −1.5 to 0.03) and prevention RR 0.78 (CI 0.50–1.23), both not significant ([Chuter et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24775807/)); pain SMD 0.61 (CI 0.36–0.85) favoring custom orthotics versus none ([Kong et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32954802/)).

### Speculative 🟨

#### Long-term joint preservation

Reduced joint loading in gait laboratories has been proposed to slow osteoarthritis (joint cartilage wear) over decades. No trial has followed insole users long enough to test this; the basis is biomechanical measurement only.

#### Early detection of mobility decline with sensor insoles

Insole pressure sensors and other wearables can record gait events during daily life ([Prasanth et al., 2021](https://pubmed.ncbi.nlm.nih.gov/33924403/)). No controlled study links insole-detected changes to falls, disability, or longevity outcomes; the basis is technical validation.

  
## Benefit-Modifying Factors

* **Genetic polymorphisms:** No gene variants are known to modify insole response. Inherited structural traits alter the indication, for example pes cavus (high-arched feet), where custom orthoses showed a clear pain benefit ([Hawke et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18646168/)).
* **Baseline biomarker levels:** Higher baseline knee pain and a measurable knee-load reduction with the wedge marked responders; 25% of screened adults failed that criterion ([Felson et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30615299/)).
* **Sex-based differences:** Insole trials rarely report sex-stratified results. Shoe selection by arch height showed the same null injury effect in men and women ([Knapik et al., 2014](https://pubmed.ncbi.nlm.nih.gov/25155917/)).
* **Pre-existing health conditions:** Diabetic neuropathy defines the ulcer-prevention benefit; varus (bow-legged) knee alignment limited pain relief from wedged insoles ([Bartsch et al., 2022](https://pubmed.ncbi.nlm.nih.gov/35929765/)).
* **Age-related considerations:** Foot pain affects at least one in four older people, and orthoses are among the effective conservative options ([Menz, 2016](https://pubmed.ncbi.nlm.nih.gov/27451329/)); older adults with recurrent falls walked slower in textured insoles at first wear ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)).
* **Adherence:** Ulcer-recurrence benefit appeared only in participants wearing footwear for at least 80% of steps, about 46% of the trial group ([Bus et al., 2013](https://pubmed.ncbi.nlm.nih.gov/24130357/)).

  
## Potential Risks & Side Effects

<!-- Author search statement: A dedicated search for the complete side effect profile was run on 2026-09-29 using PubMed (trial adverse-event reporting in orthosis and insole trials, Cochrane reviews of custom orthoses, running-economy and muscle-adaptation studies, older-adult gait studies) and a clinical reference source for orthotics (Cleveland Clinic patient library page "Orthotics", medically reviewed 08/26/2024, read on 2026-09-29), which describes a break-in period of up to one month and reports no harm from inserts. Formal drug-reference sources do not apply to these non-drug devices. -->

### High 🟥 🟥 🟥

No risk reaches High: insole harms come from single trials, small studies, and gait-laboratory measures, not from documented adverse events replicated across several trials.

### Medium 🟥 🟥

#### Blisters, arch pain, and shin pain from new orthoses

In a trial of 306 naval recruits, more participants wearing prefabricated foot orthoses reported at least one adverse event, most often foot blisters, arch pain, and shin pain, though the difference was not statistically significant. Rates in non-military adults are unmeasured, and insole trials report adverse events inconsistently ([Bonanno et al., 2018](https://pubmed.ncbi.nlm.nih.gov/29056595/)).

**Magnitude:** Any adverse event 20.3% versus 12.4% (RR 1.63, CI 0.96–2.76); blisters 6.6%, arch pain 3.3%, shin pain 2.6%; number needed to harm (NNH, people treated for one to be harmed) 13 ([Bonanno et al., 2018](https://pubmed.ncbi.nlm.nih.gov/29056595/)).

#### Slower gait with textured insoles in older fallers

In 30 adults over 65 with two or more falls in the past year, first-time use of textured insoles produced slower, shorter steps than smooth insoles, without balance changes. Prolonged-wear effects are unknown ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)).

**Magnitude:** Gait velocity 62.1 versus 66.3 centimeters per second, step length 1.2–1.8 centimeters shorter, and stride length 2.9 centimeters shorter with textured versus smooth insoles, in 26 participants with usable gait data ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)).

### Low 🟥

#### Reduced running economy in distance runners

A meta-analysis of five small laboratory studies found foot orthoses associated with a slightly higher oxygen cost of running; shock-absorbing insoles showed a similar but imprecise trend. Race performance effects were not established ([Crago et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31423908/)).

**Magnitude:** SMD 0.42 (CI 0.17–0.72) worse running economy with foot orthoses; 0.26 (CI −0.33 to 0.84) with shock-absorbing insoles ([Crago et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31423908/)).

#### Smaller intrinsic foot muscles with custom orthosis use

In 18 young adults with flat feet, 12 weeks of custom orthoses were followed by smaller cross-sectional area of three intrinsic foot muscles versus control, without change in muscle activity. Groups were small and allocated by stratified sampling (subgroup-based assignment), not randomization ([Protopapas & Perry, 2020](https://pubmed.ncbi.nlm.nih.gov/32521283/)).

**Magnitude:** Cross-sectional area fell 9.6% to 17.4%, depending on the muscle, after 12 weeks ([Protopapas & Perry, 2020](https://pubmed.ncbi.nlm.nih.gov/32521283/)).

### Speculative 🟨

#### Skin breakdown in feet with reduced sensation

Unnoticed friction or pressure from an added device could progress to skin injury in neuropathy. The basis is mechanistic reasoning, with no controlled data on insoles.

#### Contact dermatitis from insole materials

Contact dermatitis (skin allergy) to insole adhesives, dyes, or rubber components is plausible. The basis is mechanistic and isolated reports, with no controlled data on insoles.

#### Increased kneecap loading with wedged insoles

Lateral wedges were reported to increase patellofemoral (kneecap) loading in gait analyses ([Felson et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30615299/)). The basis is laboratory measurement only, without clinical outcome data.

  
## Risk-Modifying Factors

* **Genetic polymorphisms:** No variants are known to modify insole risk; hereditary neuropathies (nerve disorders) reduce protective sensation and raise skin-injury risk from any pressure device.
* **Baseline biomarker levels:** Pre-ulcers (callus, blister, fissure) and slow walking speed predicted ulceration in 60 adults with diabetes at high risk ([Hulshof et al., 2025](https://pubmed.ncbi.nlm.nih.gov/40745692/)).
* **Sex-based differences:** No sex-specific differences in insole adverse events are documented; trials report pooled results.
* **Pre-existing health conditions:** Peripheral arterial disease (reduced leg blood flow), foot deformity, and open skin lesions raise skin-breakdown risk when pressure is added.
* **Age-related considerations:** Older adults with recurrent falls walked slower in textured insoles at first wear ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)).

  
## Key Interactions & Contraindications

* **Prescription drugs affecting balance or sensation (severity: caution):** Sedatives (calming drugs such as diazepam, zolpidem) and neuropathy-causing chemotherapy (paclitaxel, cisplatin) reduce balance or foot sensation, blunting sensory-insole feedback and masking pressure injury. Daily foot inspection is the mitigation.
* **Drugs that thin skin or impair healing (severity: monitor):** Oral corticosteroids (anti-inflammatory hormone-like drugs such as prednisone) and anticoagulants (blood thinners such as warfarin, apixaban) may worsen blistering, bruising, or bleeding from friction; graded break-in and moisture-wicking socks limit exposure.
* **Over-the-counter medications (severity: monitor):** Analgesics (pain relievers such as ibuprofen, acetaminophen) may mask pain from a poorly fitting insole, delaying detection of pressure injury; skin checks replace reliance on pain.
* **Supplements:** No interactions with insoles are documented, and no supplement is known to add to or oppose their effects. Supplements taken for neuropathy or joint pain address separate targets.
* **Other interventions (severity: caution):** Insoles added to shoes with a tight toe box can raise pressure and cause skin injury; foot-strengthening exercise is complementary, and unloader knee braces may add to wedge effects.

**Populations who should avoid Insoles:**

* Active foot ulcer, foot infection, or acute Charcot foot (destructive foot deformity in neuropathy): off-the-shelf insoles are not a substitute for specialist pressure relief.
* Critical limb ischemia (severely reduced blood flow; toe pressure below 30 millimeters of mercury or ankle-to-arm blood pressure ratio below 0.4) without vascular review.
* Loss of protective sensation (failed 10-gram monofilament test, a touch test with a thin nylon filament) with rigid custom insoles not fitted or reviewed by a foot specialist.
* Adults over 65 with two or more falls in the past year using textured insoles without a supervised first trial.
* Known allergy to insole materials such as latex or adhesives.

  
## Risk Mitigation Strategies

* **Graded break-in:** Phasing wear over 1–2 weeks, for example starting at 1–2 hours daily, targets the blisters and arch or shin soreness reported by about 1 in 5 recruits in one trial ([Bonanno et al., 2018](https://pubmed.ncbi.nlm.nih.gov/29056595/)).
* **Pressure-guided fitting in feet with reduced sensation:** In-shoe pressure measurement aiming for roughly 20% peak-pressure relief, the level tested, targets pressure injury; ulcer recurrence fell significantly only with high wear adherence ([Bus et al., 2013](https://pubmed.ncbi.nlm.nih.gov/24130357/)).
* **Daily foot inspection:** Daily skin checks, with professional foot examinations every 1–3 months in high-risk diabetic feet, catch pre-ulcers (callus, blisters, fissures) before they progress.
* **Latex- and adhesive-free materials:** Choosing covers without latex or adhesive addresses possible contact dermatitis from insole materials.
* **Supervised first use of textured insoles:** In older adults with falls history, a gait-speed check at first wear addresses the slower, shorter steps seen in one study ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)).
* **Knee screening before wedged insoles:** Excluding kneecap-joint arthritis, as the pain-relief trial did, addresses the increased kneecap loading reported with lateral wedges ([Felson et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30615299/)).
* **Foot strengthening alongside orthoses:** Progressive foot exercises at least 5 days weekly for about 8 weeks increased foot muscle size, offsetting possible disuse shrinkage ([Ridge et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30113521/)).
* **Fit check:** Removing the factory insole and leaving about 1 cm beyond the longest toe prevents toe crowding and pressure injury from added thickness.

  
## Therapeutic Protocol

* **Diabetic ulcer prevention:** The Amsterdam UMC group led by Sicco Bus tests pressure-optimised custom footwear, evaluated with in-shoe pressure analysis and re-evaluated after 6 months ([NCT05236660](https://clinicaltrials.gov/study/NCT05236660)); an earlier trial aimed for about 20% peak-pressure relief ([Bus et al., 2013](https://pubmed.ncbi.nlm.nih.gov/24130357/)).
* **Plantar heel pain:** The La Trobe University podiatry group uses prefabricated contoured orthoses worn for at least 7–12 weeks; customized versions performed similarly at every time point ([Whittaker et al., 2018](https://pubmed.ncbi.nlm.nih.gov/28935689/)). Podiatrists supply both types.
* **Injury prevention in high-load training:** Contoured foot orthoses, not shock-absorbing insoles, worn through the training period, 7 to 11 weeks in trials ([Bonanno et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27919918/)).
* **Medial knee osteoarthritis:** Full-length lateral wedges of 5 degrees for 12 months ([Bennell et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21593096/)) or 6 degrees for at least 5 hours daily over 3 months ([NCT06251167](https://clinicaltrials.gov/study/NCT06251167)).
* **Sensory insoles for balance:** Textured or vibrating designs were tested mainly as immediate effects; long-term wear protocols are not standardized ([Jor et al., 2026](https://pubmed.ncbi.nlm.nih.gov/40998603/)).
* **Alternative approach:** Irene Davis (Spaulding National Running Center) advocates gradual transition to minimalist footwear ([Attia and Davis podcast](https://peterattiamd.com/irenedavis/)); minimalist-shoe walking increased foot muscle size and strength as much as exercise ([Ridge et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30113521/)). Neither is framed as default.
* **Best time of day:** No time-of-day effect has been studied; insoles are worn during weight-bearing hours, and feet swell through the day, so late-day fitting is common practice.
* **Genetic polymorphisms:** No gene variants influence protocol choice; inherited foot structure, such as high arches, changes the indication.
* **Sex-based differences:** No sex-specific protocols exist; trials report pooled results, and shoe fit differs with foot width and length.
* **Age-related considerations:** Older adults with falls history walked slower in textured insoles at first wear ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)).
* **Baseline biomarker levels:** Measured pain of at least 4 of 10 and a visible knee-load reduction guided wedge use ([Felson et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30615299/)); in-shoe pressure guides diabetic devices.
* **Pre-existing health conditions:** Diabetic neuropathy shifts care to pressure-guided devices with specialist review; rheumatoid arthritis and high-arched feet showed benefit with custom orthoses ([Hawke et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18646168/)).

  
## Discontinuation & Cycling

* **Duration:** Ulcer prevention is long-term because benefit depends on continued wear; heel pain benefit appeared at 7–12 weeks and was absent at 12 months ([Landorf et al., 2006](https://pubmed.ncbi.nlm.nih.gov/16801514/)); injury prevention applies to the training period.
* **Withdrawal effects:** No withdrawal syndrome is documented; loss of ulcer-prevention benefit follows non-wear ([Bus et al., 2013](https://pubmed.ncbi.nlm.nih.gov/24130357/)).
* **Tapering:** No taper has been trial-tested; a running-injury researcher describes reducing orthotic wear gradually while building foot strength ([Attia and Davis podcast](https://peterattiamd.com/irenedavis/)).
* **Cycling:** No evidence supports cycling insoles on and off to maintain efficacy.

  
## Sourcing and Quality

* **Prefabricated versus custom:** Off-the-shelf contoured orthoses performed similarly to custom devices for heel pain ([Whittaker et al., 2018](https://pubmed.ncbi.nlm.nih.gov/28935689/)); custom fabrication is used for diabetic offloading and structural deformity.
* **Materials and design:** Insoles differ in shell rigidity, foam density, arch height, and texture; a systematic review of balance trials found rigidity, texture, vibration thresholds, arch supports, and heel cups influenced balance effects ([Ma et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32498037/)).
* **Professional assessment:** Custom devices are made by podiatrists or orthotists from foot impressions or scans; in-shoe pressure measurement supports fabrication for diabetic feet.
* **Sensor and vibrating insoles:** Regulated device categories; trial systems were manufacturer-supplied or funded ([Abbott et al., 2019](https://pubmed.ncbi.nlm.nih.gov/33323253/)).
* **Quality signals:** No independent laboratory testing program comparable to supplement testing was found for insoles; ConsumerLab reviews none.
* **Brands:** Widely sold prefabricated brands include Superfeet and Dr. Scholl's; no independent quality ranking was found.

  
## Practical Considerations

* **Time to effect:** Heel pain benefit appeared at 7–12 weeks ([Whittaker et al., 2018](https://pubmed.ncbi.nlm.nih.gov/28935689/)); balance effects were immediate in laboratories; ulcer prevention was assessed over 12–18 months.
* **Common pitfalls:** Low adherence (only 55% of issued orthoses were worn most of the time in one trial ([Spink et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21680622/))), worn-out insoles, tight shoes, and using shock-absorbing designs for injury prevention.
* **Regulatory status:** Non-powered insoles are generally in lower-risk device categories; sensor-based systems face closer regulation.
* **Cost and accessibility:** Custom devices cost more than prefabricated ones without an advantage for heel pain ([Whittaker et al., 2018](https://pubmed.ncbi.nlm.nih.gov/28935689/)). Insurers and national systems may favor low-cost inserts or fund offloading footwear that avoids costlier ulcer care, shaping guidelines and research funding.
* **Evidence-source conflicts:** Most trials come from podiatry groups, a profession that supplies orthoses, and some device trials were manufacturer-funded ([Abbott et al., 2019](https://pubmed.ncbi.nlm.nih.gov/33323253/)).

  
## Interaction with Foundational Habits

* **Sleep:** Direction: none. No studies link insoles to sleep; they are not worn in bed. Pain relief from a foot condition could indirectly affect sleep, but this is untested.
* **Nutrition:** Direction: indirect. Insoles do not interact with diet; body weight raises plantar load, and glucose control influences neuropathy and ulcer risk in diabetes, which shapes insole indication.
* **Exercise:** Direction: indirect. Orthoses were associated with fewer stress fractures in training and slightly worse running economy ([Bonanno et al., 2017](https://pubmed.ncbi.nlm.nih.gov/27919918/); [Crago et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31423908/)); foot exercises may offset muscle shrinkage ([Ridge et al., 2019](https://pubmed.ncbi.nlm.nih.gov/30113521/)). Graded break-in applies before workouts.
* **Stress management:** Direction: none. No effect on cortisol or stress response is documented; comfortable walking may support habitual activity indirectly.

  
## Monitoring Protocol & Defining Success

Baseline assessment before starting typically documents the foot condition and risk profile: symptom rating, protective sensation, foot posture and deformity, circulation, and function tests, plus in-shoe pressure where diabetes is present. Testing uses the footwear normally worn, with any prior insoles, so later changes can be compared with the same baseline.

Ongoing monitoring follows the indication: at about 2 weeks after fitting for comfort and skin checks, at 6–12 weeks for pain outcomes, and every 6–12 months for function and device wear; in high-risk diabetic feet, skin and foot checks every 1–3 months with in-shoe pressure re-evaluation about 6 months after fitting.

| Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes |
|-----------|--------------------------|-----------------|---------------|
| Foot pain rating (0–10 scale) | Lowest tolerable; drop of at least 2 points or 30% from baseline | Tracks the main symptom target | Worst and average pain over the past week are rated; a 2-point or 30% change is the common threshold for a meaningful change |
| Protective sensation (10-gram monofilament test) | All tested sites felt | Detects sensation loss that raises ulcer risk | Relevant with diabetes or neuropathy; repeat frequency depends on risk category |
| Peak plantar pressure (in-shoe) | At least 20% below baseline; some clinics target under 200 kilopascals | Confirms pressure relief works | Measured in clinic with a pressure-sensing insole; no conventional reference range exists |
| Ankle-brachial index | 1.0–1.3 | Screens for reduced leg blood flow before pressure devices | Ratio of ankle to arm blood pressure; conventional normal 0.9–1.4, and 0.9 or below suggests arterial disease |
| Hemoglobin A1c | 4.8–5.4% | Diabetes control influences neuropathy and ulcer risk | HbA1c reflects average blood glucose over about 3 months; conventional normal below 5.7%; no fasting needed |
| Timed Up and Go test | 10 seconds or less | Screens mobility and fall risk | Timed from rising from a chair, walking 3 meters, returning, and sitting; conventional fall-risk flag is 12 seconds or more |
| Usual gait speed | 1.2 meters per second or faster | Predicts function and falls | Measured at usual walking pace over 4–10 meters; conventional concern threshold is below 0.8 meters per second |
| Single-leg stance time (eyes open) | 30 seconds or more under age 70; 15 seconds or more in the 70s | Measures balance | Conventional concern threshold is under 5 seconds |
| Toe and intrinsic foot strength | No established target; track change from own baseline | Tracks possible disuse with long-term orthosis use | Repeated with the same test, such as toe-flexion force or paper-grip time, at each visit |

Qualitative markers to track:

* Comfort and skin condition
* Walking confidence
* Fall or near-fall frequency
* Activity tolerance

  
## Emerging Research

* **Knee osteoarthritis pilot:** Multicentre insole pilot ([NCT06251167](https://clinicaltrials.gov/study/NCT06251167)); 31 adults, recruiting; compares 6-degree lateral wedges with wedges plus custom arch support, with feasibility, knee pain, foot pain, and knee-load outcomes. Earlier trials of wedges alone were null ([Bennell et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21593096/)).
* **DIASSIST:** Personalised assistive devices for diabetic foot ulcer prevention ([NCT05236660](https://clinicaltrials.gov/study/NCT05236660)); 126 adults, primary completion October 2025, results not yet identified; primary outcomes cost-utility (cost per quality-adjusted life year), wearing adherence, and ulcer recurrence at 12 months; protocol published ([Vossen et al., 2023](https://pubmed.ncbi.nlm.nih.gov/37828618/)).
* **Balance training with orthosis:** Foot orthosis in older adults ([NCT06615089](https://clinicaltrials.gov/study/NCT06615089)); 60 adults aged 65–75; primary outcome Berg Balance Scale (14-task balance test); registered as not yet recruiting, record last updated September 2024.
* **Textured wedge insoles:** Older adults with knee osteoarthritis ([NCT07097649](https://clinicaltrials.gov/study/NCT07097649)); 44 adults aged 65–75; primary outcomes chair-stand, Timed Up and Go, and balance measures; not yet recruiting.
* **Foot muscle effects:** A study of textured orthoses found higher intrinsic foot muscle activity during walking ([Robb & Perry, 2026](https://pubmed.ncbi.nlm.nih.gov/42031355/)), which could support insoles; the 12-week shrinkage finding could weaken it ([Protopapas & Perry, 2020](https://pubmed.ncbi.nlm.nih.gov/32521283/)).
* **Long-term textured insole effects:** The authors of one study state that prolonged-wear effects in older fallers remain untested ([Hatton et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22546376/)), and only 58 of 90 recruits completed the sensor-insole trial ([Abbott et al., 2019](https://pubmed.ncbi.nlm.nih.gov/33323253/)).

  
## Conclusion

Insoles are removable inserts placed in shoes to cushion, support, or add sensation to the sole of the foot. The strongest evidence, from several controlled trials, involves narrow groups: people in intense, high-volume training, where contoured inserts accompany fewer overuse bone cracks; and people with heel pain, where relief appears at about two to three months but not at one year. Moderate evidence links pressure-relieving inserts to fewer repeat foot sores in adults with reduced foot sensation from diabetes and a past sore, although results differ between trials. Evidence for balance and falls in older adults, knee arthritis, kneecap pain, and low back pain is mixed or limited to short-term laboratory measures, and several findings conflict across trials. Evidence for long-term joint protection and for digital sensor inserts is preliminary. Known harms are modest and mostly minor: blisters, arch or shin soreness, slower walking with some textured designs, lower running efficiency, and possibly smaller foot muscles with long-term use. Much of the evidence comes from podiatry departments, whose profession supplies inserts, and from device makers. Insurers and health systems, which pay for both devices and the costs of foot sores, have financial incentives that shape guidelines and research funding. For health- and longevity-oriented adults, long-term joint and mobility outcomes remain untested, and the balance between foot support and foot strengthening remains debated.

**[Top](#top) - [Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol)**
  
  
